Search Results - "WORKMAN, Creg J"

Refine Results
  1. 1

    Regulatory T Cells: Barriers of Immune Infiltration Into the Tumor Microenvironment by Scott, Ellen N, Gocher, Angela M, Workman, Creg J, Vignali, Dario A A

    Published in Frontiers in immunology (10-06-2021)
    “…Regulatory T cells (T ) are key immunosuppressive cells that promote tumor growth by hindering the effector immune response. T utilize multiple suppressive…”
    Get full text
    Journal Article
  2. 2

    The costimulatory activity of Tim-3 requires Akt and MAPK signaling and its recruitment to the immune synapse by Kataoka, Shunsuke, Manandhar, Priyanka, Lee, Judong, Workman, Creg J, Banerjee, Hridesh, Szymczak-Workman, Andrea L, Kvorjak, Michael, Lohmueller, Jason, Kane, Lawrence P

    Published in Science signaling (15-06-2021)
    “…Expression of the transmembrane protein Tim-3 is increased on dysregulated T cells undergoing chronic activation, including during chronic infection and in…”
    Get more information
    Journal Article
  3. 3

    Neuropilin-1: a checkpoint target with unique implications for cancer immunology and immunotherapy by Chuckran, Christopher A, Liu, Chang, Bruno, Tullia C, Workman, Creg J, Vignali, Dario AA

    Published in Journal for immunotherapy of cancer (01-07-2020)
    “…Checkpoint blockade immunotherapy established a new paradigm in cancer treatment: for certain patients curative treatment requires immune reinvigoration…”
    Get full text
    Journal Article
  4. 4

    Lymphocyte Activation Gene-3 (LAG-3) negatively regulates environmentally-induced autoimmunity by Jha, Vibha, Workman, Creg J, McGaha, Tracy L, Li, Liping, Vas, Jaya, Vignali, Dario A A, Monestier, Marc

    Published in PloS one (14-08-2014)
    “…Environmental factors including drugs, mineral oils and heavy metals such as lead, gold and mercury are triggers of autoimmune diseases in animal models or…”
    Get full text
    Journal Article
  5. 5

    LAG-3 Regulates Plasmacytoid Dendritic Cell Homeostasis by Workman, Creg J, Wang, Yao, El Kasmi, Karim C, Pardoll, Drew M, Murray, Peter J, Drake, Charles G, Vignali, Dario A. A

    Published in The Journal of immunology (1950) (15-02-2009)
    “…Lymphocyte activation gene 3 (LAG-3) is a CD4-related, activation-induced cell surface molecule expressed by various lymphoid cell types and binds to MHC class…”
    Get full text
    Journal Article
  6. 6

    Correction of multi-gene deficiency in vivo using a single 'self-cleaving' 2A peptide-based retroviral vector by Vignali, Dario A A, Szymczak, Andrea L, Workman, Creg J, Wang, Yao, Vignali, Kate M, Dilioglou, Smaroula, Vanin, Elio F

    Published in Nature biotechnology (01-05-2004)
    “…Attempts to generate reliable and versatile vectors for gene therapy and biomedical research that express multiple genes have met with limited success. Here we…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Interferon-γ: teammate or opponent in the tumour microenvironment? by Gocher, Angela M., Workman, Creg J., Vignali, Dario A. A.

    Published in Nature reviews. Immunology (01-03-2022)
    “…Cancer immunotherapy offers substantive benefit to patients with various tumour types, in some cases leading to complete tumour clearance. However, many…”
    Get full text
    Journal Article
  9. 9

    The CD4‐related molecule, LAG‐3 (CD223), regulates the expansion of activated T cells by Workman, CregJ., Vignali, Dario A. A.

    Published in European journal of immunology (01-04-2003)
    “…The lymphocyte activation gene‐3 (LAG‐3, CD223) is a CD4‐related, activation‐induced cell surface molecule that binds to MHC class II with high affinity. The…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Cutting Edge: Molecular Analysis of the Negative Regulatory Function of Lymphocyte Activation Gene-3 by Workman, Creg J, Dugger, Kari J, Vignali, Dario A. A

    Published in The Journal of immunology (1950) (15-11-2002)
    “…Lymphocyte activation gene (LAG)-3 (CD223) is a CD4-related activation-induced cell surface molecule that binds to MHC class II molecules with high affinity…”
    Get full text
    Journal Article
  12. 12

    LAG-3 as the third checkpoint inhibitor by Aggarwal, Vaishali, Workman, Creg J., Vignali, Dario A. A.

    Published in Nature immunology (01-09-2023)
    “…Lymphocyte activation gene 3 (LAG-3) is an inhibitory receptor that is highly expressed by exhausted T cells. LAG-3 is a promising immunotherapeutic target,…”
    Get full text
    Journal Article
  13. 13

    Phenotypic analysis of the murine CD4‐related glycoprotein, CD223 (LAG‐3) by Workman, CregJ., Rice, Dennis S., Dugger, Kari J., Kurschner, Cornelia, Vignali, Dario A. A.

    Published in European journal of immunology (01-08-2002)
    “…CD223 (LAG‐3) is an activation‐induced cell surface molecule, structurally similar to the T cell coreceptor CD4, that binds MHC class II molecules with high…”
    Get full text
    Journal Article
  14. 14
  15. 15

    On the Pathogenicity of Autoantigen-Specific T-Cell Receptors by Burton, Amanda R, Vincent, Erica, Arnold, Paula Y, Lennon, Greig P, Smeltzer, Matthew, Li, Chin-Shang, Haskins, Kathryn, Hutton, John, Tisch, Roland M, Sercarz, Eli E, Santamaria, Pere, Workman, Creg J, Vignali, Dario A A

    Published in Diabetes (New York, N.Y.) (01-05-2008)
    “…On the Pathogenicity of Autoantigen-Specific T-Cell Receptors Amanda R. Burton 1 , Erica Vincent 1 , Paula Y. Arnold 1 , Greig P. Lennon 1 , Matthew Smeltzer 2…”
    Get full text
    Journal Article
  16. 16

    Lymphocyte-activation gene 3 (LAG3): The next immune checkpoint receptor by Ruffo, Elisa, Wu, Richard C., Bruno, Tullia C., Workman, Creg J., Vignali, Dario A.A.

    Published in Seminars in immunology (01-04-2019)
    “…Immune checkpoint therapy has revolutionized cancer treatment by blocking inhibitory pathways in T cells that limits the an effective anti-tumor immune…”
    Get full text
    Journal Article
  17. 17

    Targeting regulatory T cells in tumors by Liu, Chang, Workman, Creg J., Vignali, Dario A. A.

    Published in The FEBS journal (01-07-2016)
    “…Regulatory T (Treg) cells play a crucial role in maintaining peripheral tolerance and preventing autoimmunity. However, they also represent a major barrier to…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Molecular Pathways and Mechanisms of LAG3 in Cancer Therapy by Andrews, Lawrence P, Cillo, Anthony R, Karapetyan, Lilit, Kirkwood, John M, Workman, Creg J, Vignali, Dario A A

    Published in Clinical cancer research (01-12-2022)
    “…Immunotherapy targeting coinhibitory receptors has been highly successful in treating a wide variety of malignancies; however, only a subset of patients…”
    Get full text
    Journal Article
  20. 20

    Intratumoral regulatory T cells: markers, subsets and their impact on anti‐tumor immunity by Yano, Hiroshi, Andrews, Lawrence P., Workman, Creg J., Vignali, Dario A. A.

    Published in Immunology (01-07-2019)
    “…Summary Regulatory T (Treg) cells play a crucial role in maintaining self‐tolerance and resolution of immune responses by employing multifaceted…”
    Get full text
    Journal Article